{"transactions":[{"id":702124,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:29:23.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":11883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":17323,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11883},"source":{"system":"sec-edgar","filing":"0000897069-26-001558","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001558/form4.xml","form_type":"4"}},{"id":720846,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:17:52.000Z","date":"2026-06-30","kind":"purchase","planned":false,"acquired":true,"shares":3277,"price":1.93,"value":6324.61,"ownership":{"direct":true},"balance_after":16689,"source":{"system":"sec-edgar","filing":"0000897069-26-001478","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001478/form4.xml","form_type":"4"}},{"id":735972,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-16T20:23:10.000Z","date":"2026-06-15","kind":"purchase","planned":false,"acquired":true,"shares":2654,"price":2.22,"value":5891.88,"ownership":{"direct":true},"balance_after":13412,"source":{"system":"sec-edgar","filing":"0000897069-26-001412","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001412/form4.xml","form_type":"4"}},{"id":756812,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-01T20:59:56.000Z","date":"2026-05-29","kind":"purchase","planned":false,"acquired":true,"shares":2292,"price":2.57,"value":5890.44,"ownership":{"direct":true},"balance_after":10758,"source":{"system":"sec-edgar","filing":"0000897069-26-001293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001293/form4.xml","form_type":"4"}},{"id":771533,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T21:35:26.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":1984,"price":2.97,"value":5892.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 16 shares."}],"balance_after":8466,"source":{"system":"sec-edgar","filing":"0000897069-26-001171","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001171/form4.xml","form_type":"4"}},{"id":795379,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-01T20:38:35.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":2190,"price":2.69,"value":5891.1,"ownership":{"direct":true},"balance_after":6498,"source":{"system":"sec-edgar","filing":"0000897069-26-001008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926001008/form4.xml","form_type":"4"}},{"id":805282,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:49:16.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":1984,"price":2.97,"value":5892.48,"ownership":{"direct":true},"balance_after":4308,"source":{"system":"sec-edgar","filing":"0000897069-26-000902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926000902/form4.xml","form_type":"4"}},{"id":822649,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:18:31.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":2324,"price":2.535,"value":5891.34,"ownership":{"direct":true},"balance_after":2324,"source":{"system":"sec-edgar","filing":"0000897069-26-000754","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706926000754/form4.xml","form_type":"4"}},{"id":1024268,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:27:52.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":324000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":324000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":324000},"source":{"system":"sec-edgar","filing":"0000897069-25-001547","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706925001547/form4.xml","form_type":"4"}},{"id":1024267,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:27:52.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":108000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0000897069-25-001547","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706925001547/form4.xml","form_type":"4"}},{"id":1080527,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-07-28T20:30:16.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":1775044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 1,753,212 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028."}],"balance_after":1803044,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1775044},"source":{"system":"sec-edgar","filing":"0000897069-25-001217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706925001217/form4.xml","form_type":"4"}},{"id":1451707,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-07-18T20:46:04.000Z","date":"2024-07-16","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of 50% on 7/16/25 and the remainder upon achievement of certain criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of 50% on 7/16/25 and the remainder upon achievement of certain criteria."}],"balance_after":28000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000897069-24-001518","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308105/000089706924001518/form4.xml","form_type":"4"}},{"id":1728466,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-11-28T16:02:41.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The employee stock option shall vest as follows: one-fourth of the shares shall vest on November 21, 2024, with the remaining shares vesting in 36 equal monthly installments beginning on December 21, 2024, subject to reporting person's continuous employment."}],"balance_after":50000,"derivative":{"exercise_price":3.38,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-23-121644","document":"tm2331668-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000110465923121644/tm2331668-3_4seq1.xml","form_type":"4"}},{"id":1936712,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common Stock","published_at":"2023-03-28T19:23:00.000Z","date":"2023-03-26","kind":"grant","planned":false,"acquired":true,"shares":58000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was awarded 58,000 shares of restricted common stock in connection with his service as an executive officer of the Issuer, which shares vest in four equal annual installments beginning March 26, 2023, so long as the Reporting Person's service as an employee of the Issuer is continuous from the Grant Date through the applicable anniversary thereof."}],"balance_after":75500,"source":{"system":"sec-edgar","filing":"0000899243-23-009832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000089924323009832/doc4.xml","form_type":"4"}},{"id":2057411,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Employee Stock Option  (Right to Buy)","published_at":"2023-01-10T16:29:25.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Becomes exercisable: (a) with respect to 13,125 options, when the Reporting Person completes 12 months of continuous service with the Issuer, and (b) with respect to the remaining 39,375 options, in equal monthly installments over 36 months beginning one month after the vesting commencement date of January 9, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the Grant Date through the applicable vesting date."}],"balance_after":52500,"derivative":{"exercise_price":2.82,"expiration_date":"2033-01-08","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001474506-23-000019","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000147450623000019/primary_doc.xml","form_type":"4"}},{"id":2057410,"issuer":{"id":11664,"kind":"organization","name":"ALIMERA SCIENCES INC","symbol":"ALIM"},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer & SVP"}}],"security":"Common Stock","published_at":"2023-01-10T16:29:25.000Z","date":"2023-01-09","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was awarded 17,500 shares of restricted common stock in connection with his service as an executive officer of the Issuer, which shares vest in four equal annual installments beginning January 9, 2024, so long as the Reporting Person's service as an employee of the Issuer is continuous from the Grant Date through the applicable anniversary thereof."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001474506-23-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267602/000147450623000019/primary_doc.xml","form_type":"4"}},{"id":2160463,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-13T20:30:20.000Z","date":"2022-09-09","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued employment with the Issuer."}],"balance_after":80000,"derivative":{"exercise_price":1.66,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-22-099655","document":"tm2225800-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000110465922099655/tm2225800-1_4seq1.xml","form_type":"4"}},{"id":3030486,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T01:35:03.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest upon achievement of specified milestone events."}],"balance_after":150000,"derivative":{"exercise_price":1.22,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-20-013684","document":"wf-form4_160030648779893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020013684/wf-form4_160030648779893.xml","form_type":"4"}},{"id":3030485,"issuer":{"id":7426,"kind":"organization","name":"ROCKWELL MEDICAL, INC.","symbol":"RMTI"},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T01:35:03.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest in three equal installments on the first, second and third anniversaries of September 15, 2020."}],"balance_after":600000,"derivative":{"exercise_price":1.22,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001628280-20-013684","document":"wf-form4_160030648779893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828020013684/wf-form4_160030648779893.xml","form_type":"4"}},{"id":3723875,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-12-20T13:40:49.000Z","date":"2018-12-18","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, 50% of the RSUs vested on December 18, 2018, then the remaining 25% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, 50% of the RSUs vested on December 18, 2018, then the remaining 25% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":11250,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-18-063604","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118063604/doc4.xml","form_type":"4"}},{"id":3723874,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2018-12-20T13:40:49.000Z","date":"2018-12-18","kind":"tax_withholding","acquired":false,"shares":7781,"price":1.03,"value":8014.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 22,500 RSUs, the grant of which was previously reported on a Form 8-K."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":24078,"source":{"system":"sec-edgar","filing":"0001209191-18-063604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118063604/doc4.xml","form_type":"4"}},{"id":3723873,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2018-12-20T13:40:49.000Z","date":"2018-12-18","kind":"exercise","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of Restrictive Stock Units (\"RSUs\") granted to the Reporting Person on May 24, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":31859,"source":{"system":"sec-edgar","filing":"0001209191-18-063604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118063604/doc4.xml","form_type":"4"}},{"id":3795436,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-10-09T23:18:38.000Z","date":"2018-10-04","kind":"exercise","acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, then the remaining 75% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, then the remaining 75% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":33750,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-18-054606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118054606/doc4.xml","form_type":"4"}},{"id":3795435,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2018-10-09T23:18:38.000Z","date":"2018-10-04","kind":"tax_withholding","acquired":false,"shares":3891,"price":2.22,"value":8638.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,250 RSUs, the grant of which was previously reported on a Form 8-K."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":9359,"source":{"system":"sec-edgar","filing":"0001209191-18-054606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118054606/doc4.xml","form_type":"4"}},{"id":3795434,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2018-10-09T23:18:38.000Z","date":"2018-10-04","kind":"exercise","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares earned by the Reporting Person as a result of the vesting of Restrictive Stock Units (\"RSUs\") granted to the Reporting Person on May 24, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":13250,"source":{"system":"sec-edgar","filing":"0001209191-18-054606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118054606/doc4.xml","form_type":"4"}},{"id":3990789,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Shares","published_at":"2018-03-19T23:05:53.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One quarter of the options shall vest upon the completion of continuous service from the date of grant until February 1, 2019, and the balance of the options shall vest in 36 equal monthly installments, commencing on February 1, 2019, based upon continued service."}],"balance_after":150000,"derivative":{"exercise_price":2.54,"expiration_date":"2028-03-14","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-020726","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118020726/doc4.xml","form_type":"4"}},{"id":4224913,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares, no par value","published_at":"2017-08-25T20:33:43.000Z","date":"2017-08-23","kind":"purchase","acquired":true,"shares":2000,"price":2.6424,"value":5284.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price per share represents a weighted average of prices ranging from $2.6373 to $2.6475 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include shares that may be acquired upon the exercise of certain stock options."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-17-050305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117050305/doc4.xml","form_type":"4"}},{"id":4288982,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Shares","published_at":"2017-06-08T21:18:14.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest upon the completion of continuous service from the date of grant until February 1, 2018, and the balance of the options shall vest in 36 equal monthly installments, commencing on February 1, 2018, based upon continued service."}],"balance_after":250000,"derivative":{"exercise_price":3.16,"expiration_date":"2027-06-05","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-17-038605","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117038605/doc4.xml","form_type":"4"}},{"id":4607114,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":28234,"kind":"person","name":"SKIBSTED RUSSELL","position":1,"cik":"0001308105","reported_name":"SKIBSTED RUSSELL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Shares","published_at":"2016-09-10T01:06:49.000Z","date":"2016-09-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest upon the completion of 12 months of continuous employment from the date of grant on September 8, 2016 and the balance shall vest in 36 monthly installments upon the completion of each month of continuous employment from the first anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":3.49,"expiration_date":"2026-09-07","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-16-140853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919116140853/doc4.xml","form_type":"4"}}]}